|
|
|
Volumn 25, Issue 5 SUPPL., 1998, Pages 2-11
|
|
Therapy for advanced colorectal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 ETHYNYLURACIL;
CARMUSTINE;
CISPLATIN;
DOXORUBICIN;
FLOXURIDINE;
FLUOROPYRIMIDINE DERIVATIVE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
MITOMYCIN C;
OXALIPLATIN;
THYMIDYLATE SYNTHASE INHIBITOR;
UNCLASSIFIED DRUG;
ADVANCED CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED STUDY;
DIARRHEA;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
GRANULOCYTOPENIA;
HEPATIC ARTERY;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
LIVER METASTASIS;
MAJOR CLINICAL STUDY;
META ANALYSIS;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
STOMATITIS;
THROMBOCYTOPENIA;
VOMITING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
COLORECTAL NEOPLASMS;
FLUOROURACIL;
HUMANS;
INFUSIONS, INTRA-ARTERIAL;
LIVER NEOPLASMS;
|
|
EID: 0031751228
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (49)
|
|
References (31)
|
